NCT04810741

Brief Summary

Schistosomiasis is a major public health issue. Clinical guidelines for the management of imported schistosomiasis are heterogeneous. The objective of this study is to describe the clinical management of schistosomiasis imported cases in France, regarding diagnosis, treatment and follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
532

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

December 21, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2022

Completed
Last Updated

January 13, 2023

Status Verified

March 1, 2021

Enrollment Period

5 months

First QC Date

March 19, 2021

Last Update Submit

January 12, 2023

Conditions

Schistosomiasis

Keywords

schistosomiasis, retrospective

Outcome Measures

Primary Outcomes (1)

  • Describe the management of patients with chronic schistosomiasis in France, in terms of diagnosis, assessment, management and follow-up.

    Draft of new clarified recommendations on the overall management of this pathology

    12 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years-old with a diagnosis of schistosomiasis in France

You may qualify if:

  • Age ≥ 18, positive schistosomiasis immunoblot and / or positive microscopy examination for schistosomiasis eggs

You may not qualify if:

  • \- patients under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

hospital BICETRE

Le Kremlin-Bicêtre, France

Location

MeSH Terms

Conditions

Schistosomiasis

Condition Hierarchy (Ancestors)

Trematode InfectionsHelminthiasisParasitic DiseasesInfectionsVector Borne Diseases

Study Officials

  • Stephane Jareguiberry, Professor

    APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 23, 2021

Study Start

December 21, 2021

Primary Completion

May 18, 2022

Study Completion

May 18, 2022

Last Updated

January 13, 2023

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

No sharing

Locations

FR(1)